Bigul

Zim Laboratories Ltd - 541400 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Zim Laboratories Ltd 2 CIN NO. L99999MH1984PLC032172 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2020-21, 2021-22 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 00 8Quantum of (d), which has been met from (c)(e)* 00 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 00 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21, 2021-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Piyush NikhadeDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Shyam Mohan Patro Designation : -Chief Financial Officer Date: 02/05/2022
02-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayZim Laboratories Ltd 2CINL99999MH1984PLC032172 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 33.84 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ACUITE RATINGS & RESEARCH LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Piyush Nikhade Designation: Company Secretary and Compliance Officer EmailId: cs@zimlab.in Name of the Chief Financial Officer: Shyam Mohan Patro Designation: Chief Financial Officer EmailId: shyam.patro@zimlab.in Date: 02/05/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
02-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company.

With reference to your aforementioned email dt. 22.04.2022, this is to inform you that in our opinion, the Company has disclosed all the events, information that have a bearing on the operation/performance of the company which include all price sensitive information, etc. that may have a bearing on the price behavior in the scrip. Further, the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Company shall continue to make applicable disclosures, within the stipulated time. We believe that the movement in the share price of the company is purely due to market conditions and absolutely market driven and, therefore, the Company is unable to comment on the movement in share price of the Company. You are requested to take the same on record.
25-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Clarification sought from Zim Laboratories Ltd

The Exchange has sought clarification from Zim Laboratories Ltd on April 22, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
23-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Submission Of Certificate Issued Under Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 40(10) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Certificate dt. 13.04.2022 for year ended March 31, 2022 issued under Regulation 40(9) by Practicing Company Secretary - Jagdish Patel & Co., Mumbai. This is for your information and record.
13-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Declaration With Respect To Non-Applicability Of Larger Corporate Framework.

This is to confirm that ZIM Laboratories Limited (Company) is not a 'Large Corporate' (LC) as per the criteria given under SEBI Circular SEBI/HO/DDHS/ CIR/P/2018/144 dated 26th November, 2018. Since the company was not falling under Large Corporate category as on 31st March, 2022, the requirement of filing the disclosure as mentioned in the said circular is not applicable to the Company. Kindly take the intimation on record.
12-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith Certificate dated 07.04.2022 issued by Link Intime India Private Limited, Mumbai, Registrar and Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is for your information and record.
09-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Submission Of Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Year Ended 31.03.2022.

We are submitting Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 for year ended 31.03.2022. This is for your information and record.
09-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Statement Of Investor Complaints For The Quarter Ended March 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush NikhadeDesignation :- Company Secretary and Compliance Officer
08-04-2022
Bigul

Zim Laboratories Ltd - 541400 - Closure of Trading Window

This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, BSE Circular No. LIST/COMP/2019-20 dt. 02nd April, 2019, and Company's Code of Conduct to Regulate, Monitor and Report Trading by Insider's, the trading window for dealing with securities of the Company will remain closed from Friday the 01st April, 2022, for 'Designated Persons', including Promoters / Directors / Key Managerial Personnel / Designated employees of the company and their immediate relatives. The Trading Window shall open after 48 hours of declaration of financial results of the company for the quarter and year ended 31st March, 2022.
31-03-2022
Next Page
Close

Let's Open Free Demat Account